News Center

First US Patient Dosed With Investigational Stem Cell Therapy IMS001 for MS

The first US patient has been dosed with an investigational stem cell therapy called IMS001, for multiple sclerosis (MS), developed by ImStem Biotechnology.

11/23

2021